SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-045342
Filing Date
2021-08-23
Accepted
2021-08-23 08:16:12
Documents
110
Period of Report
2021-08-23

Document Format Files

Seq Description Document Type Size
1 6-K legn-6k_20210823.htm 6-K 2387912
  Complete submission text file 0001564590-21-045342.txt   10676823

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT legn-20210823.xml EX-101.INS 2862839
3 XBRL TAXONOMY EXTENSION SCHEMA legn-20210823.xsd EX-101.SCH 104585
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE legn-20210823_cal.xml EX-101.CAL 62297
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE legn-20210823_def.xml EX-101.DEF 244519
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE legn-20210823_lab.xml EX-101.LAB 507011
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE legn-20210823_pre.xml EX-101.PRE 432138
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-317-5050
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39307 | Film No.: 211195416
SIC: 2834 Pharmaceutical Preparations